Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making?

by Judith Balmaña, Benedetta Pellegrino, Joaquin Mateo, Violeta Serra
Published 2019-04-01

Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers

by Chiara Tommasi, Chiara Tommasi, Chiara Tommasi, Benedetta Pellegrino, Benedetta Pellegrino, Benedetta Pellegrino, Daniela Boggiani, Daniela Boggiani, Angelica Sikokis, Angelica Sikokis, Maria Michiara, Vera Uliana, Beatrice Bortesi, Beatrice Bortesi, Francesco Bonatti, Paola Mozzoni, Silvana Pinelli, Anna Squadrilli, Maria Vittoria Viani, Diana Cassi, Giuseppe Maglietta, Giuseppe Maglietta, Marco Meleti, Antonino Musolino, Antonino Musolino, Antonino Musolino
Published 2021-09-01

Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis

by Benedetta Pellegrino, Giulia Mazzaschi, Denise Madeddu, Cristina Mori, Costanza Anna Maria Lagrasta, Costanza Anna Maria Lagrasta, Gabriele Missale, Gabriele Missale, Federico Quaini, Antonino Musolino, Antonino Musolino
Published 2020-02-01

A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

by Marta Castroviejo‐Bermejo, Cristina Cruz, Alba Llop‐Guevara, Sara Gutiérrez‐Enríquez, Mandy Ducy, Yasir Hussein Ibrahim, Albert Gris‐Oliver, Benedetta Pellegrino, Alejandra Bruna, Marta Guzmán, Olga Rodríguez, Judit Grueso, Sandra Bonache, Alejandro Moles‐Fernández, Guillermo Villacampa, Cristina Viaplana, Patricia Gómez, Maria Vidal, Vicente Peg, Xavier Serres‐Créixams, Graham Dellaire, Jacques Simard, Paolo Nuciforo, Isabel T Rubio, Rodrigo Dienstmann, J Carl Barrett, Carlos Caldas, José Baselga, Cristina Saura, Javier Cortés, Olivier Déas, Jos Jonkers, Jean‐Yves Masson, Stefano Cairo, Jean‐Gabriel Judde, Mark J O'Connor, Orland Díez, Judith Balmaña, Violeta Serra
Published 2018-12-01